- Why Toronto
- Startup Support
- Events & Training
- About Us
Get Social with Us
Enhancing cancer care from the beginning of a patient’s journey is critical to saving more lives.
The first thing you should know about Steve Plymale, the chief operating officer of Profound Medical, is that he used to be a competitive poker player and competed in the World Series of Poker in 2014.
Men diagnosed with localized prostate cancer have different risks of dying. In many men with “intermediate” risk, the disease appears localized and is curable with radiotherapy or surgery. But for about a third of these men, initial treatments will fail due to hidden metastasis outside the prostate.
University of Toronto scientists have uncovered more than 300 drug targets in cancer, attracting interest from the pharmaceutical industry looking to develop more precise treatments.
A new, rapid gene expression test could help clinicians determine the best management for patients with acute myeloid leukemia (AML) by making it possible to accurately predict a patient’s response to chemotherapy within one to two days of diagnosis.